'Robbing them': Treasury slams states over Trump tax cuts Experts warn the internet will go down in a big way — and you'd ...

Having low lung function as a middle-aged smoker without airway obstruction raised the likelihood for all-cause mortality, ...

The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.

The use of inhaled corticosteroids during pregnancy may protect against reduced lung function in infants born to mothers with ...

FDA Clears New Lung DrugThe US Food and Drug Administration has approved Jascayd (nerandomilast) tablets for adults with ...

A Brazilian study involving nearly 900 participants under the age of 40 reinforces the idea that premature lung aging is ...

Here are the top 5 most-read pulmonary fibrosis articles of 2025.

Progressive pulmonary fibrosis (PPF) is a life-threatening, progressive lung condition, causing a continuous decline in lung function.1,2 -- Affecting up to 100,000 people in the U.S. and up to 5.6 ...

The FDA has approved Jascayd (nerandomilast) as a treatment for a second lung disease, progressive pulmonary fibrosis, following the drug’s initial approval in October 2025 as a treatment for ...

Pulmonary exacerbations are common in children with cystic fibrosis during the first 3 years of life and are associated with ...

Air pollution, asthma, COPD & lung care explained by a pulmonologist with simple tips to protect your lungs daily.

Air pollution, particularly fine particulate matter (PM2.5), poses a major threat to our lungs, leading to health issues like ...